BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21676441)

  • 1. The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis.
    Nowfar S; Palazzi-Churas K; Chang DC; Sur RL
    Urology; 2011 Nov; 78(5):1029-33. PubMed ID: 21676441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing gender prevalence of stone disease.
    Scales CD; Curtis LH; Norris RD; Springhart WP; Sur RL; Schulman KA; Preminger GM
    J Urol; 2007 Mar; 177(3):979-82. PubMed ID: 17296391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of reno-ureteral lithiasis with ESWL in obese patients. Apropos of 150 patients].
    Muñoz RD; Tirolien PP; Belhamou S; Desta M; Grimberg R; Dulys P; Chevallier H
    Arch Esp Urol; 2003 Oct; 56(8):933-8. PubMed ID: 14639849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study.
    Lieske JC; de la Vega LS; Gettman MT; Slezak JM; Bergstralh EJ; Melton LJ; Leibson CL
    Am J Kidney Dis; 2006 Dec; 48(6):897-904. PubMed ID: 17162144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation.
    Novak TE; Lakshmanan Y; Trock BJ; Gearhart JP; Matlaga BR
    Urology; 2009 Jul; 74(1):104-7. PubMed ID: 19428065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999-2009.
    Ghani KR; Sammon JD; Karakiewicz PI; Sun M; Bhojani N; Sukumar S; Peabody JO; Menon M; Trinh QD
    BJU Int; 2013 Jul; 112(2):224-30. PubMed ID: 23480795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008.
    Stroup SP; Palazzi-Churas K; Kopp RP; Parsons JK
    BJU Int; 2012 Jan; 109(1):84-7. PubMed ID: 21615853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity.
    Rendina D; Mossetti G; De Filippo G; Benvenuto D; Vivona CL; Imbroinise A; Zampa G; Ricchio S; Strazzullo P
    Nephrol Dial Transplant; 2009 Mar; 24(3):900-6. PubMed ID: 18835844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary stone disease in Dar es Salaam.
    Mkony CA; Chuwa LM; Kahamba JF; Mteta KA; Mbembati NA
    East Afr Med J; 1991 Jun; 68(6):461-7. PubMed ID: 1752226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Equivalence in the Prevalence of Nephrolithiasis among Adults Younger than 50 Years in the United States.
    Tundo G; Khaleel S; Pais VM
    J Urol; 2018 Dec; 200(6):1273-1277. PubMed ID: 30059688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of renal and ureteral calculi.
    Knight J
    Alaska Med; 1998; 40(2):27-30. PubMed ID: 9658656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of kidney stones in Iceland: a population-based study.
    Indridason OS; Birgisson S; Edvardsson VO; Sigvaldason H; Sigfusson N; Palsson R
    Scand J Urol Nephrol; 2006; 40(3):215-20. PubMed ID: 16809263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of nephrolithiasis with prescription opioid use
.
    Pais VM; Sites BD
    Clin Nephrol; 2019 Apr; 91(4):231-236. PubMed ID: 30862351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary lithiasis in transplanted kidney].
    Lancina Martín JA; García Buitrón JM; Díaz Bermúdez J; Alvarez Castelo L; Duarte Novo J; Sánchez Merino JM; Rubial Moldes M; González Martín M
    Arch Esp Urol; 1997 Mar; 50(2):141-50. PubMed ID: 9206940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management.
    Ng CS; Yost A; Streem SB
    J Urol; 2000 Mar; 163(3):726-9. PubMed ID: 10687965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.